Literature DB >> 12511908

Harnessing immunity for cancer marker discovery.

Sam Hanash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12511908     DOI： 10.1038/nbt0103-37

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  18 in total

Review 1.  Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer.

Authors:  Bong Kyung Shin; Hong Wang; Samir Hanash
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 2.  Molecular screening of cancer: the future is here.

Authors:  Sudhir Srivastava
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 3.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

Review 4.  Advances in proteomic strategies toward the early detection of lung cancer.

Authors:  Mohamed Hassanein; Jamshedur S M Rahman; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2011-05

Review 5.  Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma.

Authors:  Yu Hong; Jian Huang
Journal:  World J Hepatol       Date:  2015-06-18

6.  Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Authors:  Li Zhong; Giovanna E Hidalgo; Arnold J Stromberg; Nada H Khattar; James R Jett; Edward A Hirschowitz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

7.  Identification of CLP36 as a tumor antigen that induces an antibody response in pancreatic cancer.

Authors:  Su-Hyung Hong
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

8.  Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.

Authors:  Ji Qiu; Gina Choi; Lin Li; Hong Wang; Sharon J Pitteri; Sandra R Pereira-Faca; Alexei L Krasnoselsky; Timothy W Randolph; Gilbert S Omenn; Cim Edelstein; Matt J Barnett; Mark D Thornquist; Gary E Goodman; Dean E Brenner; Ziding Feng; Samir M Hanash
Journal:  J Clin Oncol       Date:  2008-09-15       Impact factor: 44.544

9.  Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.

Authors:  Animesh Barua; Seby L Edassery; Pincas Bitterman; Jacques S Abramowicz; Angela L Dirks; Janice M Bahr; Dale B Hales; Michael J Bradaric; Judith L Luborsky
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

10.  Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Authors:  Ola Blixt; Deanna Bueti; Brian Burford; Diane Allen; Sylvain Julien; Michael Hollingsworth; Alex Gammerman; Ian Fentiman; Joyce Taylor-Papadimitriou; Joy M Burchell
Journal:  Breast Cancer Res       Date:  2011-03-08       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.